Doctoral Thesis
Refine
Document Type
- Doctoral Thesis (2) (remove)
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2) (remove)
Keywords
- Virus-host interaction (2) (remove)
Plus‐strand RNA [(+)RNA] viruses are the largest group of viruses, medically highly relevant human pathogens, and are a socio‐economic burden. The current global pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) shows how a virus has been rapidly spreading around the globe and that– without an antiviral treatment– virus trans mission is solely dependent on human behavior. However, other (+)RNA viruses such as rhino‐, noro‐, dengue‐ (DENV), Zika, and hepatitis C virus (HCV) are constantly spreading and expanding geographically. As in the case of hepatitis C, since its first identification in the 1970s, it took more than 30 years to understand the HCV structure, genome organiza t ion, life cycle, and virus‐host interplay leading to the cure of a chronic and life‐threatening disease. However, no vaccination or antiviral treatment exists for most (+)RNA viruses. Con sequently, a precise and comprehensive analysis of the viruses, their life cycles, and parasitic interactions with their hosts remains an important field of research. In the presented thesis, we use mathematical modeling to study the life cycles of (+)RNA viruses. We analyze replication strategies of closely related (+)RNA viruses, namely HCV, DENV, and coxsackievirus B3 (CVB3), to compare their life cycles in the presence and ab sence of the host’s immune response and antiviral drug treatment and consider different viral spreading mechanisms. Host dependency factors shape the viral life cycle, contribut ing to permissiveness and replication efficiency. Our mathematical models predicted that host dependency factors, such as ribosomes, and thus the virus’ ability to hijack the host cell’s translation machinery play an essential role in the viral genome replication efficiency. Furthermore, our mathematical model suggested that the availability of ribosomes in the vi ral life cycle is a crucial factor in disease outcome: the development of an acute or chronic disease. Even though the host developed strategies to attack the virus, e.g., by degrading the viral genome, blocking the viral protein production, and preventing viral spread, viruses found strategies to countermeasure those so‐called host restriction factors derived from the immune system. Our mathematical models predicted that DENV might be highly effective in blocking the cell’s attempts to recognize the invader. Moreover, we found ongoing HCV RNAreplication even with highly effective antiviral drugs that block processes in the viral life cycle. Furthermore, we found alternative pathways of infection spread, e.g., by HCV RNA carrying exosomes, which may be a possible explanation for reported plasma HCV RNA at the end of treatment, found in a subset of patients. Hence, the mathematical models presented in this thesis provide valuable tools to study the viral replication mechanism in detail. Even though being a simplification of reality, our model predictions confirm and explain known and suggest novel biological mechanisms. In the pre sented thesis, I will summarize and discuss key findings and contextualize model predictions in the broader scientific literature to improve our understanding of the viral dynamics and the virus‐host interplay.
Ebolaviruses are dependent on host cell proteins for almost all steps in their viral life cycle. While some cellular factors with crucial roles in the ebolavirus life cycle have been identified, many of them remain to be identified or fully characterised. This thesis focuses on the characterisation and identification of host cell interactions of the highly pathogenic Ebola virus (EBOV), probing host-virus interaction at various stages of the viral life cycle. Beginning with viral budding, the function of a recently proposed late domain motif within the EBOV matrix protein VP40 was examined using an EBOV transcription and replication-competent virus-like particle (trVLP) system. Although this motif has been suggested to interact with the endosomal sorting complex required for transport (ESCRT), we could show that this late domain motif does not contribute to EBOV budding.
While many host cell proteins have been identified so far that are important for viral budding, only a few proteins are known that are necessary for EBOV RNA synthesis. Thus, to identify host proteins that are involved in viral replication and transcription, we performed a genome-wide siRNA screen in the context of an EBOV minigenome assay. Using this approach, we identified several proteins that appear to be important for viral RNA synthesis or protein expression. Two of the most prominent hits in our screen were CAD (Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase and dihydroorotase) and NXF1 (nuclear RNA export factor 1). CAD catalyses the first three steps in the de novo pyrimidine biosynthesis, while NXF1 is the main nuclear export protein for cellular mRNAs. In subsequent characterisation studies, using a range of life cycle modelling systems as well as molecular analyses, we could demonstrate that the canonical function of CAD during the pyrimidine biosynthesis is necessary for EBOV replication and transcription. In contrast to this, for NXF1 we discovered a so-far unknown function: Again, by applying different life cycle modelling alongside with molecular assays, we provided evidence that the EBOV nucleoprotein recruits NXF1 into inclusion bodies, the site of EBOV RNA synthesis, where it binds viral mRNAs to export them from these structures. Importantly, for both CAD and NXF1 we were able to recapitulate key data in the context of live EBOV infection, confirming their roles in the viral life cycle.
Both of these identified host factors are promising targets for antiviral therapies and indeed de novo pyrimidine synthesis is emerging as a possible antiviral target for a number of viruses. Similarly, as we could show NXF1 to be important in the life cycle of the highly pathogenic Junín virus, this raises the possibility that disruption of this interaction may result in broad-spectrum antiviral activity. Moreover, for an increasing number of negative-sense RNA viruses inclusion bodies as site of viral RNA synthesis are described to have a liquid organelle character. Therefore, our findings on NXF1 also provide an intriguing model to explain how negative-sense RNA viruses in general overcome this obstacle and export viral mRNAs from inclusion bodies.